Evoke Pharma, Inc.
USD11.00
+11.00 (+0.00%)
CEO
Mark A. Kowieski
IPO Date
2013-09-25
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$11.00
Prev. Close
$11.00
Day Low
$11.00
Day High
$11.00
52W Low
$1.94
52W High
$11.00
Market Cap
$0.02B
Volume
0.05M
| -0.5 |
| 31 Dec 2022 | FY | 85.2% | -327.8% | -201.3% | -69.4% | 1.26 | 7.08 | -1.0 |
| 31 Dec 2021 | FY | 79.7% | -527.7% | -240.2% | -80.8% | 1.41 | 7.51 | -2.1 |
| 31 Dec 2020 | FY | -276.7% | -57144.5% | 409.2% | -139.4% | -1.63 | 1.23 | -5.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -162.7% | -111.4% | 0.03 | 3.10 | -5.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -188.0% | -133.7% | 0.00 | 3.46 | -5.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -564.7% | -154.0% | 0.00 | 3.82 | -2.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -283.8% | -115.6% | 0.00 | 6.58 | -1.8 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -349.8% | -127.2% | 1.26 | 5.19 | -1.8 |
| -1.1 |
| 31 Mar 2025 | Q1 | 98.6% | -42.4% | -22.4% | -8.0% | 0.88 | 1.55 | -1.3 |
| 31 Dec 2024 | Q4 | 96.4% | -36.1% | -16.9% | -6.8% | 0.73 | 1.66 | -1.4 |
| 30 Sept 2024 | Q3 | 96.1% | -49.4% | -29.9% | -9.3% | 1.14 | 1.44 | -1.3 |
| 30 Jun 2024 | Q2 | 98.4% | -49.7% | -47.6% | -10.4% | 1.88 | 1.28 | -1.5 |
| 31 Mar 2024 | Q1 | 94.7% | -91.0% | -45.2% | -12.7% | 1.43 | 1.39 | -0.8 |
| 31 Dec 2023 | Q4 | 96.5% | -118.6% | 77.0% | -28.1% | -3.88 | 0.71 | -0.4 |
| 30 Sept 2023 | Q3 | 97.8% | -108.4% | 193.9% | -21.6% | -5.74 | 3.50 | -0.7 |
| 30 Jun 2023 | Q2 | 94.9% | -165.1% | -347.0% | -20.8% | 9.39 | 4.29 | -0.7 |